Search filters

List of works by Sandrine Aspeslagh

3D waterfall plots: a better graphical representation of tumor response in oncology.

scientific article

Acquired EGFR Mutation as the Potential Resistance Driver to Crizotinib in a MET-Mutated Tumor.

scientific article published on 18 December 2015

Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection

scientific article

An in silico approach for modelling T-helper polarizing iNKT cell agonists

scientific article (publication date: 2014)

Are phase I trials safe for older patients?

scientific article published on 7 September 2017

Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells

scientific article published on 29 July 2013

Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors).

scientific article published on 18 August 2017

CD70 Expression and Its Correlation with Clinicopathological Variables in Squamous Cell Carcinoma of the Head and Neck

scientific article published on 8 July 2016

Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation

scientific article

Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.

scientific article published on 8 September 2017

Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies

scientific article

Divergent synthetic approach to 6''-modified α-GalCer analogues ⬇️

scientific article

Enhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor Protection

scientific article

Epigenetic modifiers as new immunomodulatory therapies in solid tumours

scientific article published on 7 February 2018

Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis

scientific article

Immuno-oncology-101: overview of major concepts and translational perspectives

scientific article published on 8 February 2018

Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours

scientific article published on 7 April 2018

In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?

scientific article published on 7 November 2017

Invariant natural killer T cells in rheumatic disease: a joint dilemma

scientific article published on February 2010

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

scientific article published on 25 April 2016

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

scientific article published on 27 February 2017

Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells

scientific article published on November 2003

Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors

scientific article

Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors

scientific article published on 8 September 2016

Phase I dose-escalation study of plitidepsin in combination with sorafenib or gemcitabine in patients with refractory solid tumors or lymphomas

scientific article

Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model

scientific article

Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes

scientific article

Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score).

scientific article

RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study

scientific article published on 22 July 2017

Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy

scientific article published on 20 July 2016

Rationale for anti-OX40 cancer immunotherapy

scientific article

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

scientific article published on 10 January 2018

Synthesis and evaluation of amino-modified alpha-GalCer analogues

scientific article published on July 2010

Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands

scientific article published on 12 October 2012

Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists

scientific article

TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?

scientific article published on 28 December 2016

Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer

scientific article published on 6 July 2017

Turning the tide: Clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck

scientific article

Paulina is supported by:

About Paulina

Help